Get the Stockscreener App
1.03
5.50%
-0.06
Aditxt Inc stock is traded at $1.03, with a volume of 209.68K.
It is down -5.50% in the last 24 hours and down -14.88% over the past month.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
See More
Previous Close:
$1.09
Open:
$1.08
24h Volume:
209.68K
Relative Volume:
0.28
Market Cap:
$2.50M
Revenue:
$212.10K
Net Income/Loss:
$-40.19M
P/E Ratio:
-0.000194
EPS:
-5313.2836
Net Cash Flow:
$-13.92M
1W Performance:
-13.45%
1M Performance:
-14.88%
6M Performance:
-96.16%
1Y Performance:
-99.99%
1-Day Range:
$1.02
$1.08
1-Week Range:
$1.02
$1.25
52-Week Range:
$1.02
$21,400.00
Aditxt Inc Stock (ADTX) Company Profile
Name
Aditxt Inc
Sector
Industry
Phone
909-488-0844
Address
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
1.03 | 2.65M | 212.10K | -40.19M | -13.92M | -5,313.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Aditxt Inc Stock (ADTX) Latest News
Should I hold or sell Aditxt Inc. stock in 2025Expert Picks Target Finder For Consistent Profits - jammulinksnews.com
Is it the right time to buy Aditxt Inc. stockFree Stock Alerts For Every Investor - jammulinksnews.com
Aditxt subsidiary Pearsanta engages Spartan Capital for planned IPO - Investing.com Australia
Aditxt subsidiary Pearsanta engages Spartan Capital for planned IPO By Investing.com - Investing.com India
Breakthrough Cancer Detection Company Pearsanta Announces IPO Plans to Scale Early Disease Detection Platform - Stock Titan
Published on: 2025-07-29 11:27:13 - metal.it
How does Aditxt Inc. generate profit in a changing economyMarket Forecast Opportunities Backed By Experts - jammulinksnews.com
What is the risk reward ratio of investing in Aditxt Inc. stockUnlock exclusive stock analysis for investors - jammulinksnews.com
Does Aditxt Inc. stock perform well during market downturnsTake advantage of unprecedented market momentum - jammulinksnews.com
Is Aditxt Inc. a growth stock or a value stockMassive stock growth - jammulinksnews.com
What catalysts could drive Aditxt Inc. stock higher in 2025Master stock selection with insider knowledge - jammulinksnews.com
How strong is Aditxt Inc. company’s balance sheetBuild a winning investment strategy today - jammulinksnews.com
Published on: 2025-07-28 06:09:36 - jammulinksnews.com
Published on: 2025-07-28 06:07:17 - jammulinksnews.com
Why is Aditxt Inc. stock attracting strong analyst attentionDynamic growth stocks - jammulinksnews.com
How does Aditxt Inc. compare to its industry peersTriple-digit growth rates - jammulinksnews.com
What are Aditxt Inc. company’s key revenue driversInvest smarter with daily trading signals - jammulinksnews.com
How volatile is Aditxt Inc. stock compared to the marketOutstanding investment returns - jammulinksnews.com
Should I buy Aditxt Inc. stock before earningsConsistent triple-digit returns - jammulinksnews.com
What analysts say about Aditxt Inc. stockHigh-velocity capital appreciation - PrintWeekIndia
What drives Aditxt Inc. stock priceFree Stock Market Knowledge Sharing - PrintWeekIndia
Aditxt Inc.'s Subsidiary Pearsanta Advances in DoD-Funded Ovarian Cancer Diagnostic Study - citybuzz -
Aditxt CEO Highlights Immunotherapy at Investor Event - TipRanks
Aditxt’s Subsidiary Pearsanta Receives an Invitation to Submit Full Proposal for the U.S. Department of Defense Pilot Award for the Development of its Mitomic® Ovarian Test | Dow Theory Letters - FinancialContent
Is Aditxt Inc. a good long term investmentMassive portfolio appreciation - jammulinksnews.com
Aditxt Inc. Stock Analysis and ForecastRapidly expanding wealth - jammulinksnews.com
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
Aditxt to Present at Wall Street Reporter’s Next Super Stock Livestream Today July 22, 2025, at 1 p.m. ET - FinancialContent
Aditxt Showcases Pearsanta’s Diagnostic Advancements - TipRanks
Aditxt Inc Stock (ADTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aditxt Inc Stock (ADTX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Oct 16 '24 |
Sale |
1.17 |
25,534 |
29,875 |
0 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):